This inventor holds 1 USPTO granted patent. Top assignee: Macau University of Science and Technology. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Innovation in Rheumatoid Arthritis Treatment by Cong Ling Qiu
Introduction
Cong Ling Qiu, an innovative researcher based in Taipa, MO, has made significant contributions to the field of medical treatments for rheumatoid arthritis. With a focus on addressing complex cases, particularly those associated with p53 mutations, his work has the potential to change many lives.
Latest Patents
Cong Ling Qiu holds a patent for a method of treating refractory rheumatoid arthritis associated with p53 mutation. This method involves the administration of an effective amount of a quinonemethide triterpenoid or a pharmaceutically tolerable salt, solvate, or anhydrate thereof to the patient. Additionally, his invention includes techniques for inducing autophagy and calcium mobilization in synovial fibroblasts, alongside a pharmaceutical composition containing an effective dose of quinonemethide triterpenoid and an anti-arthritis compound. The research emphasizes the quinonemethide triterpenoid’s efficacy in treating refractory rheumatoid arthritis, especially types that are ABC-protein-dependent and apoptosis-deficient.
Career Highlights
Cong is affiliated with the Macau University of Science and Technology, where he engages in groundbreaking research that intertwines biochemistry and pharmacology. His work not only advances our understanding of rheumatoid arthritis but opens new pathways for therapeutic interventions.
Collaborations
Throughout his career, Cong Ling Qiu has collaborated with esteemed colleagues such as Liang Liu and Kam Wai Wong. These partnerships foster an environment of shared knowledge and innovation, further enhancing the impact of their research on arthritis treatments.
Conclusion
Cong Ling Qiu's contributions to the treatment of rheumatoid arthritis demonstrate the critical role of innovation in addressing chronic medical conditions. His patented methods and research initiatives are set to pave the way for new therapeutic strategies, possibly transforming the lives of those suffering from this challenging disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile